A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers
Crossref DOI link: https://doi.org/10.1007/s00228-017-2342-z
Published Online: 2017-10-19
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xiao, Feng
Zhang, Feng
Zhang, Ling-ling
Wei, Wei
Funding for this research was provided by:
National Natural Science Foundation of China (81330081, 81473223)
License valid from 2017-10-19